These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37881139)

  • 1. The therapeutic effect of engineered phage, derived protein and enzymes against superbug bacteria.
    Boroujeni MB; Mohebi S; Malekian A; Shahraeini SS; Gharagheizi Z; Shahkolahi S; Sadeghi RV; Naderifar M; Akbarizadeh MR; Soltaninejad S; Moghadam ZT; Moghadam MT; Mirzadeh F
    Biotechnol Bioeng; 2024 Jan; 121(1):82-99. PubMed ID: 37881139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically engineered phages and engineered phage-derived enzymes to destroy biofilms of antibiotics resistance bacteria.
    Eghbalpoor F; Gorji M; Alavigeh MZ; Moghadam MT
    Heliyon; 2024 Aug; 10(15):e35666. PubMed ID: 39170521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriophages as a potential substitute for antibiotics: A comprehensive review.
    Kushwaha SO; Sahu SK; Yadav VK; Rathod MC; Patel D; Sahoo DK; Patel A
    Cell Biochem Funct; 2024 Apr; 42(3):e4022. PubMed ID: 38655589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far.
    Łusiak-Szelachowska M; Międzybrodzki R; Drulis-Kawa Z; Cater K; Knežević P; Winogradow C; Amaro K; Jończyk-Matysiak E; Weber-Dąbrowska B; Rękas J; Górski A
    J Biomed Sci; 2022 Mar; 29(1):23. PubMed ID: 35354477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of phage-antibiotic combination strategy on multidrug-resistant Acinetobacter baumannii biofilms.
    Erol HB; Kaskatepe B; Yildiz S; Altanlar N
    J Microbiol Methods; 2023 Jul; 210():106752. PubMed ID: 37268109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
    Tagliaferri TL; Jansen M; Horz HP
    Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How Phages Overcome the Challenges of Drug Resistant Bacteria in Clinical Infections.
    Taati Moghadam M; Amirmozafari N; Shariati A; Hallajzadeh M; Mirkalantari S; Khoshbayan A; Masjedian Jazi F
    Infect Drug Resist; 2020; 13():45-61. PubMed ID: 32021319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biofilm control with natural and genetically-modified phages.
    Motlagh AM; Bhattacharjee AS; Goel R
    World J Microbiol Biotechnol; 2016 Apr; 32(4):67. PubMed ID: 26931607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phage and phage cocktails formulations.
    Mani I
    Prog Mol Biol Transl Sci; 2023; 200():159-169. PubMed ID: 37739554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteriophages: The promising therapeutic approach for enhancing ciprofloxacin efficacy against bacterial infection.
    Shariati A; Noei M; Chegini Z
    J Clin Lab Anal; 2023 May; 37(9-10):e24932. PubMed ID: 37377167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of therapeutic phage cocktail and endolysin to highly multi-drug resistant
    Jasim HN; Hafidh RR; Abdulamir AS
    Iran J Basic Med Sci; 2018 Nov; 21(11):1100-1108. PubMed ID: 30483382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli.
    Valério N; Oliveira C; Jesus V; Branco T; Pereira C; Moreirinha C; Almeida A
    Virus Res; 2017 Aug; 240():8-17. PubMed ID: 28746884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against
    Rossitto M; Fiscarelli EV; Rosati P
    Front Microbiol; 2018; 9():775. PubMed ID: 29780361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of Phage-Antibiotic Combinations against Staphylococcus aureus Biofilms.
    Kebriaei R; Lehman SM; Shah RM; Stamper KC; Kunz Coyne AJ; Holger D; El Ghali A; Rybak MJ
    Microbiol Spectr; 2023 Jun; 11(3):e0491822. PubMed ID: 37199616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiofilm Efficacy of the Pseudomonas aeruginosa Pbunavirus vB_PaeM-SMS29 Loaded onto Dissolving Polyvinyl Alcohol Microneedles.
    Sillankorva S; Pires L; Pastrana LM; Bañobre-López M
    Viruses; 2022 May; 14(5):. PubMed ID: 35632706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered phage enzymes against drug-resistant pathogens: a review on advances and applications.
    Hassannia M; Naderifar M; Salamy S; Akbarizadeh MR; Mohebi S; Moghadam MT
    Bioprocess Biosyst Eng; 2024 Mar; 47(3):301-312. PubMed ID: 37962644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal Synergism between Phage YC#06 and Antibiotics: a Combination Strategy to Target Multidrug-Resistant Acinetobacter baumannii
    Luo J; Xie L; Liu M; Li Q; Wang P; Luo C
    Microbiol Spectr; 2022 Aug; 10(4):e0009622. PubMed ID: 35736241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phage therapy, an additional strategy against multidrug-resistant bacteria].
    Boniver M; Wotquenne P; Moutschen M; Rousseau AF
    Rev Med Liege; 2022 Sep; 77(9):510-515. PubMed ID: 36082597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phage steering of antibiotic-resistance evolution in the bacterial pathogen,
    Gurney J; Pradier L; Griffin JS; Gougat-Barbera C; Chan BK; Turner PE; Kaltz O; Hochberg ME
    Evol Med Public Health; 2020; 2020(1):148-157. PubMed ID: 34254028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.